IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
about
IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
IFI44L is a novel tumor suppre ...... ing met/Src signaling pathway.
@en
IFI44L is a novel tumor suppre ...... ing met/Src signaling pathway.
@nl
type
label
IFI44L is a novel tumor suppre ...... ing met/Src signaling pathway.
@en
IFI44L is a novel tumor suppre ...... ing met/Src signaling pathway.
@nl
prefLabel
IFI44L is a novel tumor suppre ...... ing met/Src signaling pathway.
@en
IFI44L is a novel tumor suppre ...... ing met/Src signaling pathway.
@nl
P2093
P2860
P1433
P1476
IFI44L is a novel tumor suppre ...... ing met/Src signaling pathway.
@en
P2093
Pei-Yi Chu
Po-Ming Chen
Shiao-Lin Tung
Wei-Chieh Huang
Yao-Li Chen
P2860
P2888
P356
10.1186/S12885-018-4529-9
P407
P577
2018-05-30T00:00:00Z
P6179
1104302429